SG11201408107RA - Method for quantifying immune cells in tumoral tissues and its applications - Google Patents
Method for quantifying immune cells in tumoral tissues and its applicationsInfo
- Publication number
- SG11201408107RA SG11201408107RA SG11201408107RA SG11201408107RA SG11201408107RA SG 11201408107R A SG11201408107R A SG 11201408107RA SG 11201408107R A SG11201408107R A SG 11201408107RA SG 11201408107R A SG11201408107R A SG 11201408107RA SG 11201408107R A SG11201408107R A SG 11201408107RA
- Authority
- SG
- Singapore
- Prior art keywords
- paris
- rue
- international
- immune cells
- medecine
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2012001446 | 2012-06-14 | ||
| PCT/EP2013/062405 WO2013186374A1 (en) | 2012-06-14 | 2013-06-14 | Method for quantifying immune cells in tumoral tissues and its applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201408107RA true SG11201408107RA (en) | 2015-01-29 |
Family
ID=46881097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201408107RA SG11201408107RA (en) | 2012-06-14 | 2013-06-14 | Method for quantifying immune cells in tumoral tissues and its applications |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10317408B2 (he) |
| EP (1) | EP2861986B1 (he) |
| JP (1) | JP6449765B2 (he) |
| KR (1) | KR102179848B1 (he) |
| CN (1) | CN104541167B (he) |
| AU (1) | AU2013276470B2 (he) |
| BR (1) | BR112014031143B8 (he) |
| CA (1) | CA2873278C (he) |
| DE (1) | DE13731071T1 (he) |
| ES (1) | ES2902879T3 (he) |
| IL (1) | IL235738B (he) |
| SG (1) | SG11201408107RA (he) |
| WO (1) | WO2013186374A1 (he) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2701092T5 (es) | 2014-02-24 | 2022-05-12 | Ventana Med Syst Inc | Procedimientos, kits y sistemas para puntuar la respuesta inmunitaria al cáncer por detección simultánea de CD3, CD8, CD20 y FOXP3 |
| EP3195191B1 (en) * | 2014-09-03 | 2020-10-21 | Ventana Medical Systems, Inc. | Systems and methods for calculating immune scores |
| EP3215852A4 (en) * | 2014-11-05 | 2018-04-04 | The Regents of the University of California | Methods for stratifying non-responders to therapies that block pd1/pdl1 axis |
| US10632151B2 (en) | 2015-01-22 | 2020-04-28 | University Of Massachusetts | Cancer immunotherapy |
| CN108136216B (zh) * | 2015-10-23 | 2021-08-24 | 诺华股份有限公司 | 对包含肿瘤组织的样品评分的方法 |
| CN115198018A (zh) * | 2016-05-09 | 2022-10-18 | 法国国家卫生及研究医学协会 | 患有实体癌症的患者的分类方法 |
| EP3889893B1 (en) * | 2016-05-18 | 2022-03-30 | F. Hoffmann-La Roche AG | Tumor proximity measure |
| CN110168561B (zh) * | 2016-10-27 | 2023-06-16 | 皇家飞利浦有限公司 | 用于确定一个或多个组织样本中的细胞组成信息的装置 |
| EP3532638A4 (en) | 2016-10-31 | 2020-07-29 | University of Massachusetts | TARGETING MICROARN-101-3 P IN CARCINOTHERAPY |
| CN106846310A (zh) * | 2017-01-19 | 2017-06-13 | 宁波江丰生物信息技术有限公司 | 一种基于免疫组化技术的病理辅助分析方法 |
| EP3659110A1 (en) * | 2017-07-24 | 2020-06-03 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in tumor samples |
| US11814623B2 (en) | 2018-01-30 | 2023-11-14 | University Of Massachusetts | Methods of treating a wound using epigenetic regulation |
| WO2020161125A1 (en) * | 2019-02-05 | 2020-08-13 | Ventana Medical Systems, Inc. | Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer |
| WO2020245155A1 (en) | 2019-06-03 | 2020-12-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for modulating a treatment regimen |
| CA3151629A1 (en) | 2019-11-07 | 2021-05-14 | Laura E. BENJAMIN | Classification of tumor microenvironments |
| CN111551546B (zh) * | 2020-06-01 | 2023-01-03 | 南京瑟斯检测科技有限公司 | 一种基于光学微腔结构超材料的免疫组化便捷检测方法 |
| JP2023531305A (ja) | 2020-06-30 | 2023-07-21 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 術前補助療法後の固形癌患者の再発及び／又は死亡のリスクを予測するための方法。 |
| JP2023531290A (ja) | 2020-06-30 | 2023-07-21 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 術前補助療法及び根治手術後の固形がんを患っている患者の再発及び／又は死亡のリスクを予測するための方法 |
| TWI838687B (zh) * | 2021-01-30 | 2024-04-11 | 奇美醫療財團法人奇美醫院 | 評估腫瘤標本免疫狀態的方法 |
| CN113092202A (zh) * | 2021-03-25 | 2021-07-09 | 上海福君基因生物科技有限公司 | 一种胃癌预后预测装置 |
| CN113515077A (zh) * | 2021-04-23 | 2021-10-19 | 重庆德方信息技术有限公司 | 人体细胞染色过程监控系统及方法 |
| WO2023018085A1 (ko) * | 2021-08-10 | 2023-02-16 | 주식회사 루닛 | 병리 슬라이드 이미지와 관련된 정보를 출력하는 방법 및 장치 |
| WO2023175366A1 (en) | 2022-03-17 | 2023-09-21 | Veracyte | Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer |
| CN116646088B (zh) * | 2023-07-27 | 2023-12-01 | 广东省人民医院 | 一种预测方法、装置、设备及介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE236386T1 (de) * | 1995-11-30 | 2003-04-15 | Chromavision Med Sys Inc | Verfahren zur automatischen bildanalyse biologischer proben |
| EP1777523A1 (en) * | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| CN101341387B (zh) * | 2005-12-19 | 2013-02-13 | 泛塔纳医药系统公司 | 解剖病理学中的自动精益方法 |
| US9240043B2 (en) | 2008-09-16 | 2016-01-19 | Novartis Ag | Reproducible quantification of biomarker expression |
| FR2964744B1 (fr) * | 2010-09-10 | 2015-04-03 | Univ Versailles St Quentin En Yvelines | Test pronostic de l'evolution d'une tumeur solide par analyse d'images |
-
2013
- 2013-06-14 ES ES13731071T patent/ES2902879T3/es active Active
- 2013-06-14 SG SG11201408107RA patent/SG11201408107RA/en unknown
- 2013-06-14 JP JP2015516637A patent/JP6449765B2/ja active Active
- 2013-06-14 CA CA2873278A patent/CA2873278C/en active Active
- 2013-06-14 US US14/407,698 patent/US10317408B2/en active Active
- 2013-06-14 CN CN201380030888.7A patent/CN104541167B/zh active Active
- 2013-06-14 AU AU2013276470A patent/AU2013276470B2/en active Active
- 2013-06-14 WO PCT/EP2013/062405 patent/WO2013186374A1/en active Application Filing
- 2013-06-14 DE DE13731071.0T patent/DE13731071T1/de active Pending
- 2013-06-14 KR KR1020157000987A patent/KR102179848B1/ko active IP Right Grant
- 2013-06-14 BR BR112014031143A patent/BR112014031143B8/pt active IP Right Grant
- 2013-06-14 EP EP13731071.0A patent/EP2861986B1/en active Active
-
2014
- 2014-11-17 IL IL235738A patent/IL235738B/he active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2873278A1 (en) | 2013-12-19 |
| AU2013276470A1 (en) | 2014-11-27 |
| WO2013186374A1 (en) | 2013-12-19 |
| DE13731071T1 (de) | 2016-08-18 |
| IL235738B (he) | 2019-02-28 |
| EP2861986A1 (en) | 2015-04-22 |
| BR112014031143B8 (pt) | 2022-11-22 |
| KR20150023760A (ko) | 2015-03-05 |
| BR112014031143A2 (pt) | 2017-08-08 |
| JP2015525349A (ja) | 2015-09-03 |
| CA2873278C (en) | 2021-10-26 |
| BR112014031143B1 (pt) | 2022-03-03 |
| CN104541167B (zh) | 2018-05-01 |
| JP6449765B2 (ja) | 2019-01-09 |
| US20150153349A1 (en) | 2015-06-04 |
| IL235738A0 (he) | 2015-01-29 |
| ES2902879T3 (es) | 2022-03-30 |
| KR102179848B1 (ko) | 2020-11-17 |
| EP2861986B1 (en) | 2021-11-10 |
| AU2013276470B2 (en) | 2018-06-07 |
| US10317408B2 (en) | 2019-06-11 |
| CN104541167A (zh) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201408107RA (en) | Method for quantifying immune cells in tumoral tissues and its applications | |
| SG11201809294RA (en) | Systems and methods for sensor data analysis through machine learning | |
| SG11201809317VA (en) | Methods for classifying patients with a solid cancer | |
| SG11201900772YA (en) | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors | |
| SG11202000073XA (en) | Anti-cd8 antibodies and uses thereof | |
| SG11201407668XA (en) | Method and device for detecting an analyte in a body fluid | |
| SG11201803666WA (en) | Single image detection | |
| SG11201804127SA (en) | Ctla4 binders | |
| SG11201408385TA (en) | Methods of detecting diseases or conditions | |
| SG11201908865WA (en) | Apparatus and method for absolute quantification of biomarkers for solid tumor diagnosis | |
| SG11201804563SA (en) | Digital microfluidic system for single-cell isolation and characterization of analytes | |
| SG11201901545RA (en) | Noncontact detection method of sleep stages and sleep-disordered breathing | |
| SG11201908240YA (en) | Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device | |
| SG11201406903SA (en) | Cell culture compositions and methods for polypeptide production | |
| SG11201811405QA (en) | Improved differentiation method | |
| SG11201908847TA (en) | Apparatuses, systems and methods for imaging flow cytometry | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201407226WA (en) | Improved methods of cell culture for adoptive cell therapy | |
| SG11201906238TA (en) | Split sector level sweep using beamforming refinement frames | |
| SG11201908767QA (en) | Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy | |
| SG11201906413XA (en) | Exposure apparatus | |
| SG11201407459QA (en) | System and method for predicting the immunogenicity of a peptide | |
| SG11201407294UA (en) | Contamination identification system | |
| SG11201901611YA (en) | Methods for the identification, targeting and isolation of human dendritic cell (dc) precursors "pre-dc" and their uses thereof | |
| SG11201909501TA (en) | Personalized 3d neural culture system for generating human oligodendrocytes and studying myelination in vitro |